Ampelopsins A and C Induce Apoptosis and Metastasis through Downregulating AxL, TYRO3, and FYN Expressions in MDA-MB-231 Breast Cancer Cells

Journal of Agricultural and Food Chemistry
Cheng HuangHsiu-Chen Huang

Abstract

Ampelopsins A and C are resveratrol oligostilbenes whose role in cancer development remains unknown. This study evaluated the antimetastatic and apoptosis-inducing properties of ampelopsins A and C in MDA-MB-231 cells. The IC50 values of ampelopsins A and C against MDA-MB-231 cells at 72 h were 38.75 ± 4.61 and 2.71 ± 0.21 μM, respectively. However, at 24 h, ampelopsins A and C decreased cell metastasis significantly. Among the 71 proteins present on the human phosphoreceptor tyrosin kinase array, ampelopsin C decreased the phosphorylated protein level of AXL, Dtk (TYRO3), EphA2, EphA6, Fyn, Hck, and SRMS. Additionally, antiproliferation effects of ampelopsin C were enhanced when combined with luteolin and chrysin compared to either two or a single agent in MDA-MB-231 cells. Overall, ampelopsins A and C extracted from Vitis thunbergii are both novel antimetastatic agents and potential therapeutic targets in patients with breast cancer.

References

Dec 1, 1980·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Carmo-PereiraE Henriques
Feb 26, 2005·Journal of Natural Products·Yu-Ling HuangChien-Chih Chen
Jan 29, 2008·Recent Patents on Cardiovascular Drug Discovery·Samarjit Das, Dipak K Das
Mar 7, 2009·Planta medica·Wen-Fei ChiouYu-Ling Huang
Sep 3, 2010·Expert Opinion on Therapeutic Targets·Rachel M A LingerDouglas K Graham
Jun 24, 2011·Nature·Scott A SnyderMaria I Chiriac
May 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Yu-Ling HuangWen-Fei Chiou
Apr 12, 2014·Journal of Medicinal Food·Ching-Fent TsaiChing-Chiung Wang
May 7, 2014·Oxidative Medicine and Cellular Longevity·You-Qiu XueZhi Shi
Jun 7, 2014·Journal of Clinical Pathology·Timothy M D'AlfonsoSandra J Shin
Oct 21, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yanyan LiYongfu Zhao
Oct 23, 2014·Oncotarget·Xiaoliang WuBalazs Halmos
Sep 10, 2016·BMC Complementary and Alternative Medicine·Napsiah Abd RahmanSharida Fakurazi
Jan 11, 2017·British Journal of Cancer·Carl M GayLauren Averett Byers
Jul 18, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chi-I ChangJue-Liang Hsu
Mar 20, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Inês AmaralFátima Martel
Apr 24, 2018·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Laetitia NivelleDominique Delmas

❮ Previous
Next ❯

Citations

Jun 21, 2019·Current Topics in Medicinal Chemistry·Zhi-Gang SunYong Qian
Mar 10, 2020·Journal of Oncology·Sierra A Colavito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.